Guidelines developed for perinatal hematologic cancers

Guidelines developed for perinatal hematologic cancers

(HealthDay)—Consensus guidelines have been developed for clinical management of hematologic malignancies during the perinatal period, according to a special article published online Nov. 30 in the Journal of Clinical Oncology.

Noting that the incidence of is increasing as women delay conception, and that a favorable prognosis is contingent on early diagnosis and treatment, Michael Lishner, M.D., from the Meir Medical Center in Kfar Saba, Israel, and colleagues developed guidelines for of hematologic malignancies during the . A team, which included an experienced hematologist/oncologist; a high-risk obstetrics specialist; a neonatologist; and experienced nurses, social workers, and psychologists, developed these guidelines. The draft was revised until final consensus was reached.

The team reviewed diagnostic and novel therapeutic approaches and integrated new information into treatment protocols. The guidelines relate to diagnostic procedures, chemotherapy use, radiotherapy use, and maternal supportive care. The authors also address perinatal and pediatric aspects of care.

"This consensus summary equips with novel diagnostic and treatment methodologies that aim for optimal treatment of the mother, while protecting fetal and pediatric health," the authors write.

Several authors disclosed financial ties to the biopharmaceutical industry.


Explore further

AAP provides guidance on pediatric peri-op anesthesia

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Journal of Clinical Oncology

Copyright © 2015 HealthDay. All rights reserved.

Citation: Guidelines developed for perinatal hematologic cancers (2015, December 7) retrieved 12 November 2019 from https://medicalxpress.com/news/2015-12-guidelines-perinatal-hematologic-cancers.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments